 Invitae Corp NYSE: NVTA has agreed to acquire consumer health technology company Ciitizen for 325 million in a bid to make it easier for patients to collect their genomic and clinical information. Ciitizen, backed by several investors, including a16z, Section 32, and Verily, is building a digital platform that will enable patients to collect, store, and share their medical records. 